Sosei Heptares’ COVID-19 programme advances promising molecules
R&D programme is focused on developing small molecules against SARS-CoV-2 virus
Read More
Tag: Small molecule
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
